Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue, first described by Raun and colleagues in 1998 as the first selective growth hormone secretagogue. It remains one of the most extensively characterised compounds of its class in the published research literature
Zepbound, Semaglutide GLP-1, and Wegovy are all GLP-1 receptor agonists used for weight loss, but they work slightly differently
The present study provides preliminary evidence in favor of the GLP-1 based therapies in providing beneficial effects against atherosclerosis as indicated by the significant reductions in atherosclerosis markers including BNP, PAI-1 and hsCRP, besides statistically non-significant reductions in several other markers including IMT, FMD, IL-6 and TNF- were also noted
Autorreparacin
[13] Treatment was given for 104 weeks (2 years), and the occurrence of cardiovascular events, including heart attacks, strokes, and hospitalization due to unstable angina (near heart attack) were recorded and compared in the two groups of participants
Scholten, R